EPIDUO FORTE
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $109.68 | 7 | 7 |
| 2021 | $66,942 | 305 | 244 |
| 2020 | $485,116 | 3,125 | 1,362 |
| 2019 | $617,939 | 7,932 | 2,678 |
| 2018 | $1.1M | 10,877 | 3,219 |
| 2017 | $1.2M | 11,770 | 3,384 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2.0M | 1,451 | 56.7% |
| Food and Beverage | $713,463 | 31,198 | 20.6% |
| Unspecified | $405,963 | 86 | 11.7% |
| Travel and Lodging | $151,539 | 825 | 4.4% |
| Consulting Fee | $137,030 | 47 | 4.0% |
| Grant | $87,714 | 3 | 2.5% |
| Education | $4,097 | 406 | 0.1% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| EFFICACY AND SAFETY OF ADAPALENE 0.35BENZOYL PEROXIDE 2.5 GEL PLUS DOXYCYCLINE IN SEVERE INFLAMMATORY ACNE NON-NODULOCYSTIC SUBJECTS | Galderma Laboratories, L.P. | $405,963 | 7 |
Top Doctors Receiving Payments for EPIDUO FORTE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Hershey, PA | $278,505 | 69 |
| , M.D | Dermatology | Brooklyn, NY | $132,105 | 162 |
| , M.D | Dermatology | West Bloomfield, MI | $115,517 | 156 |
| , MD | Dermatology | Lousiville, KY | $102,982 | 23 |
| , MD | Dermatology | New York, NY | $99,179 | 166 |
| , MD | Dermatology | Midvale, UT | $97,192 | 179 |
| , D.O | Dermatology | Bryn Mawr, PA | $90,834 | 183 |
| , MD | Dermatology | Birmingham, AL | $85,967 | 100 |
| , DO | MOHS-Micrographic Surgery | Las Vegas, NV | $54,592 | 27 |
| , M.D | Clinical & Laboratory Dermatological Immunology | Ann Arbor, MI | $54,452 | 103 |
| , M.D | Dermatology | Sacramento, CA | $54,438 | 85 |
| , MD | Dermatology | Nottingham, MD | $51,799 | 94 |
| , MD PHD | Dermatology | Jacksonville, FL | $51,370 | 113 |
| , M.D | Dermatology | Northbrook, IL | $50,920 | 114 |
| , M.D | Procedural Dermatology | Largo, MD | $45,995 | 68 |
| , D.O | Dermatology | Morristown, NJ | $44,392 | 71 |
| , MD | Dermatology | Saint Louis, MO | $41,240 | 88 |
| , MD | MOHS-Micrographic Surgery | Boca Raton, FL | $40,205 | 71 |
| , MD | Pediatric Dermatology | San Antonio, TX | $39,794 | 43 |
| , D.O | Dermatology | Newport Beach, CA | $38,898 | 103 |
| , MD | Dermatology | Houston, TX | $37,955 | 76 |
| , MD | Dermatology | San Francisco, CA | $37,106 | 96 |
| , MD | MOHS-Micrographic Surgery | Fort Smith, AR | $35,597 | 17 |
| , MD | Dermatology | Grapevine, TX | $34,102 | 93 |
| , M.D | Student in an Organized Health Care Education/Training Program | Somerset, NJ | $33,840 | 69 |
Manufacturing Companies
Product Information
- Type Drug
- Total Payments $3.5M
- Total Doctors 5,771
- Transactions 34,016
About EPIDUO FORTE
EPIDUO FORTE is a drug associated with $3.5M in payments to 5,771 healthcare providers, recorded across 34,016 transactions in the CMS Open Payments database. The primary manufacturer is Galderma Laboratories, L.P..
Payment data is available from 2017 to 2022. In 2022, $109.68 was paid across 7 transactions to 7 doctors.
The most common payment nature for EPIDUO FORTE is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($2.0M, 56.7% of total).
EPIDUO FORTE is associated with 1 research study, including "EFFICACY AND SAFETY OF ADAPALENE 0.35BENZOYL PEROXIDE 2.5 GEL PLUS DOXYCYCLINE IN SEVERE INFLAMMATORY ACNE NON-NODULOCYSTIC SUBJECTS" ($405,963).